Improving personalized treatment for Parkinson's disease using shared clinical data
Advancing personalized medicine in PD using harmonized multi-site clinical data
This study is looking to improve treatment for people with Parkinson's disease by gathering and analyzing data from different clinics to better understand how symptoms and responses to treatments vary, so that doctors can create personalized care plans that adapt to each person's needs over time.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-11159267 on NIH RePORTER |
What this research studies
This research aims to enhance personalized medicine for individuals with Parkinson's disease (PD) by analyzing clinical data from multiple sites. It focuses on understanding the diverse symptoms and treatment responses among patients to create tailored treatment strategies. By leveraging large datasets and longitudinal assessments, the project seeks to identify effective treatment sequences that can adapt to the changing needs of patients over time. The goal is to develop individualized treatment plans that promote better health outcomes for those living with PD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease who may benefit from tailored treatment approaches.
Not a fit: Patients with Parkinson's disease who are not seeking personalized treatment strategies or those with advanced stages of the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with Parkinson's disease.
How similar studies have performed: Previous research has shown promise in using large datasets for personalized medicine approaches, indicating potential success for this novel application in Parkinson's disease.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Ertefaie, Ashkan — University of Rochester
- Study coordinator: Ertefaie, Ashkan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.